Stock screenerAll disclosures →
EDGAR →
TRVI
Conviction 100HealthcareScan · Fri, Jun 26, 2026TRVI$18.10+0.56%
ResistanceSupportVol 14Vol MA14 2.33M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price18.10
Change+0.56%
Gap+0.67%
Rel volume2.21×
Avg volume1.9M
Avg $ vol30.72M
SMA 2015.14
SMA 5014.67
SMA 20012.08
Price vs 50+23.34%
Price vs 200+49.83%
MA stackbullish
50/200 cross—
Supertrendup · 15.49
RSI (14)76
MACD hist0.39
MACD crossbull · 8d
Stoch %K / %D96 / 93
ADX (14)36
+DI / −DI34 / 7
RSI divergence—
MACD divergence—
ATR %+4.47%
ADR %4.89%
52w high18.10
52w low5.47
From 52w high+0.00%
Above 52w low+230.90%
New 52w highYes
SqueezeOff
Bollinger width47.57%
%B0.91
Donchian pos95.89%
Donchian high18.31
Donchian low13.20
AVWAP (52w high)18.01
vs AVWAP high+0.48%
AVWAP (52w low)11.06
vs AVWAP low+63.61%
OBV trendUp
Chaikin MF (20)0.05
Today vs 20d2.21×
Avg vol (14d)2.33M
Avg vol (20d)1.9M
Avg $ vol (20d)30.72M
Market cap—
RS 3m (vs SPY)+45.55%
RS 6m (vs SPY)+34.06%
RS line new highYes
Trend template8/8
Technical rank92.4
1 week+5.17%
1 month+25.26%
3 months+53.39%
6 months+41.19%
1 year+218.66%
YTD+52.23%
P/E-59.70
P/B14.83
P/S—
P/FCF-60.63
EPS-0.3200
Div yield—
ROE-24.84%
ROA-23.81%
Debt/Eq—
Current24.75
EV/EBITDA-51.51
Gross margin—
Net margin—
Rev growth—
EPS growth10.75%
Price target24.43
Target upside35.87%
Analyst ratingBuy
Institutional99.60%
Ent. value2.53B
Revenue—
Net income-13.19M
Gross profit—
Free cash flow-42.1M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out141.98M
Employees34
ListedFri, May 3, 2019
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank92.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.98
Support13.19
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TRVI
No recent disclosed trades by Congress in TRVI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TRVI · 5 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Meeker David P Director · Nonstatutory Stock Option (right to buy) · 2026-06-03 | Grant | 35K | $0 | 2026-06-03 | 2026-06-04 |
Mathers Edward T Director · Nonstatutory Stock Option (right to buy) · 2026-06-03 | Grant | 35K | $0 | 2026-06-03 | 2026-06-04 |
Colangelo Dominick Director · Nonstatutory Stock Option (right to buy) · 2026-06-03 | Grant | 35K | $0 | 2026-06-03 | 2026-06-04 |
VANLENT ANNE Director · Nonstatutory Stock Option (right to buy) · 2026-06-03 | Grant | 35K | $0 | 2026-06-03 | 2026-06-04 |
Heffernan Michael Thomas Director · Nonstatutory Stock Option (right to buy) · 2026-06-03 | Grant | 35K | $0 | 2026-06-03 | 2026-06-04 |
SEC filings
EDGAR filings in TRVI · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.